Literature DB >> 12199770

Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.

Drew Provan1, Adrian Newland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199770     DOI: 10.1046/j.1365-2141.2002.03669.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  18 in total

Review 1.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

2.  Borderline thrombocytopenia or mild idiopathic thrombocytopenic purpura?

Authors:  Jacques Zimmer; François Hentges; Emmanuel Andres
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

3.  Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.

Authors:  Kiarash Kojouri; James N George
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

4.  Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure.

Authors:  Samo Zver; Irena Preloznik Zupan; Peter Cernelc
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

5.  Evaluation of 143 cases of immune thrombocytopenic purpura with regards to clinical course and response to treatment.

Authors:  Murat Albayrak; Ozlem Sahin Balcik; Sahika Zeynep Aki; Ayla Gokmen; Funda Ceran; Osman Yokus; Simten Dagdas; Meltem Ayli; Gulsum Ozet
Journal:  Eurasian J Med       Date:  2010-12

6.  Severe Thrombocytopenia in an Immune Thrombocytopenic Parturient Non-responder to Medical Line of Treatment: Anaesthetic Management for Splenectomy Combined with Caesarean Section.

Authors:  Vikas Karne; Meenal Patil
Journal:  Indian J Hematol Blood Transfus       Date:  2011-07-14       Impact factor: 0.900

7.  Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle.

Authors:  Andreas Rank; Oliver Weigert; Helmut Ostermann
Journal:  Biologics       Date:  2010-05-25

8.  Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy.

Authors:  Jae Joon Han; Sun Kyung Baek; Jae Jin Lee; Si-Young Kim; Kyung Sam Cho; Hwi-Joong Yoon
Journal:  Korean J Hematol       Date:  2010-09-30

Review 9.  Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol.

Authors:  Emmanuel Andrès; Jacques Zimmer; Esther Noel; Georges Kaltenbach; Argyro Koumarianou; Frédéric Maloisel
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Prediction of response to splenectomy in patients with idiopathic thrombocytopenic purpura.

Authors:  A Shojaiefard; S A Mousavi; S H Faghihi; S Abdollahzade
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.